COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
Go back to COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs(NASDAQ: CMPS) | Delayed: 8.10 -0.15 (1.82%) | |||||
---|---|---|---|---|---|---|
Previous Close | $8.25 | 52 Week High | $ | |||
Open | $8.30 | 52 Week Low | $ | |||
Day High | $8.38 | P/E | N/A | |||
Day Low | $7.89 | EPS | $ | |||
Volume | 887,823 |
(NASDAQ: CMPS) | Delayed: 8.10 -0.15 (1.82%) | |||||
---|---|---|---|---|---|---|
Previous Close | $8.25 | 52 Week High | $ | |||
Open | $8.30 | 52 Week Low | $ | |||
Day High | $8.38 | P/E | N/A | |||
Day Low | $7.89 | EPS | $ | |||
Volume | 887,823 |